Literature DB >> 19759306

Neuropathy target esterase is required for adult vertebrate axon maintenance.

David J Read1, Yong Li, Moses V Chao, John B Cavanagh, Paul Glynn.   

Abstract

The enzyme neuropathy target esterase (NTE) is present in neurons and deacylates the major membrane phospholipid, phosphatidylcholine (PtdCho). Mutation of the NTE gene or poisoning by neuropathic organophosphates--chemical inhibitors of NTE--causes distal degeneration of long spinal axons in humans. However, analogous neuropathological changes have not been reported in nestin-cre:NTEfl/fl mice with NTE-deficient neural tissue. Furthermore, altered PtdCho homeostasis has not been detected in NTE-deficient vertebrates. Here, we describe distal degeneration of the longest spinal axons in approximately 3-week-old nestin-cre:NTEfl/fl mice and in adult C57BL/6J mice after acute dosing with a neuropathic organophosphate: in both groups early degenerative lesions were followed by swellings comprising accumulated axoplasmic material. In mice dosed acutely with organophosphate, maximal numbers of lesions, in the longest spinal sensory axon tract, were attained within days and were preceded by a transient rise in neural PtdCho. In nestin-cre:NTEfl/fl mice, sustained elevation of PtdCho over many months was accompanied by progressive degeneration and massive swelling of axons in sensory and motor spinal tracts and by increasing hindlimb dysfunction. Axonal lesion distribution closely resembled that in hereditary spastic paraplegia (HSP). The importance of defective membrane trafficking in HSP and the association of NTE with the endoplasmic reticulum--the starting point for the constitutive secretory pathway and transport of neuronal materials into axons--prompted investigation for a role of NTE in secretion. Cultured NTE-deficient neurons displayed modestly impaired secretion, consistent with neuronal viability and damage in vivo initially restricted to distal parts of the longest axons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759306      PMCID: PMC3849655          DOI: 10.1523/JNEUROSCI.3007-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

1.  A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition.

Authors:  Anne Tarrade; Coralie Fassier; Sabrina Courageot; Delphine Charvin; Jérémie Vitte; Leticia Peris; Alain Thorel; Etienne Mouisel; Nuria Fonknechten; Natacha Roblot; Danielle Seilhean; Andrée Diérich; Jean Jacques Hauw; Judith Melki
Journal:  Hum Mol Genet       Date:  2006-11-13       Impact factor: 6.150

Review 2.  The Sec14-superfamily and the regulatory interface between phospholipid metabolism and membrane trafficking.

Authors:  Carl J Mousley; Kimberly R Tyeryar; Patrick Vincent-Pope; Vytas A Bankaitis
Journal:  Biochim Biophys Acta       Date:  2007-04-12

Review 3.  Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms.

Authors:  Sara Salinas; Christos Proukakis; Andrew Crosby; Thomas T Warner
Journal:  Lancet Neurol       Date:  2008-12       Impact factor: 44.182

4.  Atlastin GTPases are required for Golgi apparatus and ER morphogenesis.

Authors:  Neggy Rismanchi; Cynthia Soderblom; Julia Stadler; Peng-Peng Zhu; Craig Blackstone
Journal:  Hum Mol Genet       Date:  2008-02-12       Impact factor: 6.150

5.  Neuropathy target esterase gene mutations cause motor neuron disease.

Authors:  Shirley Rainier; Melanie Bui; Erin Mark; Donald Thomas; Debra Tokarz; Lei Ming; Colin Delaney; Rudy J Richardson; James W Albers; Nori Matsunami; Jeff Stevens; Hilary Coon; Mark Leppert; John K Fink
Journal:  Am J Hum Genet       Date:  2008-02-28       Impact factor: 11.025

6.  Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease.

Authors:  Koei Shinzawa; Hisae Sumi; Masahito Ikawa; Yosuke Matsuoka; Masaru Okabe; Saburo Sakoda; Yoshihide Tsujimoto
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

Review 7.  Amyloid precursor protein trafficking, processing, and function.

Authors:  Gopal Thinakaran; Edward H Koo
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

8.  The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate-induced delayed neurotoxicity in hens.

Authors:  Wei-Yuan Hou; Ding-Xin Long; Hui-Ping Wang; Qi Wang; Yi-Jun Wu
Journal:  Toxicology       Date:  2008-08-05       Impact factor: 4.221

9.  Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation.

Authors:  P N Lacor; D R Grayson; J Auta; I Sugaya; E Costa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners.

Authors:  Christopher M Sanderson; James W Connell; Thomas L Edwards; Nicholas A Bright; Simon Duley; Amanda Thompson; J Paul Luzio; Evan Reid
Journal:  Hum Mol Genet       Date:  2005-12-08       Impact factor: 6.150

View more
  34 in total

1.  Compound heterozygous PNPLA6 mutations cause Boucher-Neuhäuser syndrome with late-onset ataxia.

Authors:  A Deik; B Johannes; J C Rucker; E Sánchez; S E Brodie; E Deegan; K Landy; Y Kajiwara; S Scelsa; R Saunders-Pullman; C Paisán-Ruiz
Journal:  J Neurol       Date:  2014-09-30       Impact factor: 4.849

Review 2.  Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown.

Authors:  Samantha J Merwin; Teresa Obis; Yanelli Nunez; Diane B Re
Journal:  Arch Toxicol       Date:  2017-01-09       Impact factor: 5.153

3.  Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474.

Authors:  Annelot C M van Esbroeck; Antonius P A Janssen; Armand B Cognetta; Daisuke Ogasawara; Guy Shpak; Mark van der Kroeg; Vasudev Kantae; Marc P Baggelaar; Femke M S de Vrij; Hui Deng; Marco Allarà; Filomena Fezza; Zhanmin Lin; Tom van der Wel; Marjolein Soethoudt; Elliot D Mock; Hans den Dulk; Ilse L Baak; Bogdan I Florea; Giel Hendriks; Luciano De Petrocellis; Herman S Overkleeft; Thomas Hankemeier; Chris I De Zeeuw; Vincenzo Di Marzo; Mauro Maccarrone; Benjamin F Cravatt; Steven A Kushner; Mario van der Stelt
Journal:  Science       Date:  2017-06-09       Impact factor: 47.728

4.  Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.

Authors:  Nichole D Hein; Jeanne A Stuckey; Shirley R Rainier; John K Fink; Rudy J Richardson
Journal:  Toxicol Lett       Date:  2010-04-09       Impact factor: 4.372

5.  Spg20-/- mice reveal multimodal functions for Troyer syndrome protein spartin in lipid droplet maintenance, cytokinesis and BMP signaling.

Authors:  Benoît Renvoisé; Julia Stadler; Rajat Singh; Joanna C Bakowska; Craig Blackstone
Journal:  Hum Mol Genet       Date:  2012-05-22       Impact factor: 6.150

Review 6.  Hereditary spastic paraplegias: membrane traffic and the motor pathway.

Authors:  Craig Blackstone; Cahir J O'Kane; Evan Reid
Journal:  Nat Rev Neurosci       Date:  2011-01       Impact factor: 34.870

Review 7.  Phosphatidylcholine and the CDP-choline cycle.

Authors:  Paolo Fagone; Suzanne Jackowski
Journal:  Biochim Biophys Acta       Date:  2012-09-23

8.  The destruction box is involved in the degradation of the NTE family proteins by the proteasome.

Authors:  Fei-Fei Huang; Ping-An Chang; Lan-Xi Sun; Wen-Zhen Qin; Li-Ping Han; Rui Chen
Journal:  Mol Biol Rep       Date:  2016-08-24       Impact factor: 2.316

Review 9.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

Review 10.  Cellular pathways of hereditary spastic paraplegia.

Authors:  Craig Blackstone
Journal:  Annu Rev Neurosci       Date:  2012-04-20       Impact factor: 12.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.